This report contains market size and forecasts of Critical Care Therapeutics in Global, including the following market information:
Global Critical Care Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Critical Care Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Critical Care Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Critical Care Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Critical Care Therapeutics Market Segment Percentages, By Type, 2020 (%)
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates
China Critical Care Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Critical Care Therapeutics Market Segment Percentages, By Application, 2020 (%)
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Other
Global Critical Care Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Critical Care Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Critical Care Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Critical Care Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Critical Care Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Critical Care Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Critical Care Therapeutics Overall Market Size
2.1 Global Critical Care Therapeutics Market Size: 2021 VS 2027
2.2 Global Critical Care Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Critical Care Therapeutics Players in Global Market
3.2 Top Global Critical Care Therapeutics Companies Ranked by Revenue
3.3 Global Critical Care Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Critical Care Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Critical Care Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Critical Care Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Critical Care Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Critical Care Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Critical Care Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Albumin
4.1.3 Prothrombin Complex Concentrates
4.1.4 Antithrombin Concentrates
4.1.5 Factor XIII Concentrates
4.1.6 Fibrinogen Concentrates
4.2 By Type - Global Critical Care Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Critical Care Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Critical Care Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Critical Care Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Critical Care Therapeutics Market Size, 2021 & 2027
5.1.2 Pulmonary Embolism (PE)
5.1.3 Acute Coronary Syndrome
5.1.4 Atrial Fibrillation
5.1.5 Other
5.2 By Application - Global Critical Care Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Critical Care Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Critical Care Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Critical Care Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Critical Care Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Critical Care Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Critical Care Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Critical Care Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Critical Care Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Critical Care Therapeutics Revenue, 2016-2027
6.3.2 US Critical Care Therapeutics Market Size, 2016-2027
6.3.3 Canada Critical Care Therapeutics Market Size, 2016-2027
6.3.4 Mexico Critical Care Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Critical Care Therapeutics Revenue, 2016-2027
6.4.2 Germany Critical Care Therapeutics Market Size, 2016-2027
6.4.3 France Critical Care Therapeutics Market Size, 2016-2027
6.4.4 U.K. Critical Care Therapeutics Market Size, 2016-2027
6.4.5 Italy Critical Care Therapeutics Market Size, 2016-2027
6.4.6 Russia Critical Care Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Critical Care Therapeutics Market Size, 2016-2027
6.4.8 Benelux Critical Care Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Critical Care Therapeutics Revenue, 2016-2027
6.5.2 China Critical Care Therapeutics Market Size, 2016-2027
6.5.3 Japan Critical Care Therapeutics Market Size, 2016-2027
6.5.4 South Korea Critical Care Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Critical Care Therapeutics Market Size, 2016-2027
6.5.6 India Critical Care Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Critical Care Therapeutics Revenue, 2016-2027
6.6.2 Brazil Critical Care Therapeutics Market Size, 2016-2027
6.6.3 Argentina Critical Care Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Critical Care Therapeutics Revenue, 2016-2027
6.7.2 Turkey Critical Care Therapeutics Market Size, 2016-2027
6.7.3 Israel Critical Care Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Critical Care Therapeutics Market Size, 2016-2027
6.7.5 UAE Critical Care Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 CSL Behring
7.1.1 CSL Behring Corporate Summary
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Critical Care Therapeutics Major Product Offerings
7.1.4 CSL Behring Critical Care Therapeutics Revenue in Global (2016-2021)
7.1.5 CSL Behring Key News
7.2 Grifols
7.2.1 Grifols Corporate Summary
7.2.2 Grifols Business Overview
7.2.3 Grifols Critical Care Therapeutics Major Product Offerings
7.2.4 Grifols Critical Care Therapeutics Revenue in Global (2016-2021)
7.2.5 Grifols Key News
7.3 Kedrion Biopharma
7.3.1 Kedrion Biopharma Corporate Summary
7.3.2 Kedrion Biopharma Business Overview
7.3.3 Kedrion Biopharma Critical Care Therapeutics Major Product Offerings
7.3.4 Kedrion Biopharma Critical Care Therapeutics Revenue in Global (2016-2021)
7.3.5 Kedrion Biopharma Key News
7.4 Octapharma
7.4.1 Octapharma Corporate Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Critical Care Therapeutics Major Product Offerings
7.4.4 Octapharma Critical Care Therapeutics Revenue in Global (2016-2021)
7.4.5 Octapharma Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Critical Care Therapeutics Major Product Offerings
7.5.4 Takeda Critical Care Therapeutics Revenue in Global (2016-2021)
7.5.5 Takeda Key News
7.6 Bayer HealthCare
7.6.1 Bayer HealthCare Corporate Summary
7.6.2 Bayer HealthCare Business Overview
7.6.3 Bayer HealthCare Critical Care Therapeutics Major Product Offerings
7.6.4 Bayer HealthCare Critical Care Therapeutics Revenue in Global (2016-2021)
7.6.5 Bayer HealthCare Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Critical Care Therapeutics Major Product Offerings
7.4.4 Merck Critical Care Therapeutics Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 Mitsubishi Tanabe Pharma
7.8.1 Mitsubishi Tanabe Pharma Corporate Summary
7.8.2 Mitsubishi Tanabe Pharma Business Overview
7.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue in Global (2016-2021)
7.8.5 Mitsubishi Tanabe Pharma Key News
7.9 REVO Biologics
7.9.1 REVO Biologics Corporate Summary
7.9.2 REVO Biologics Business Overview
7.9.3 REVO Biologics Critical Care Therapeutics Major Product Offerings
7.9.4 REVO Biologics Critical Care Therapeutics Revenue in Global (2016-2021)
7.9.5 REVO Biologics Key News
7.10 Rockwell Medical
7.10.1 Rockwell Medical Corporate Summary
7.10.2 Rockwell Medical Business Overview
7.10.3 Rockwell Medical Critical Care Therapeutics Major Product Offerings
7.10.4 Rockwell Medical Critical Care Therapeutics Revenue in Global (2016-2021)
7.10.5 Rockwell Medical Key News
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Corporate Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Critical Care Therapeutics Major Product Offerings
7.11.4 Thermo Fisher Scientific Critical Care Therapeutics Revenue in Global (2016-2021)
7.11.5 Thermo Fisher Scientific Key News
7.12 Shanghai RAAS
7.12.1 Shanghai RAAS Corporate Summary
7.12.2 Shanghai RAAS Business Overview
7.12.3 Shanghai RAAS Critical Care Therapeutics Major Product Offerings
7.12.4 Shanghai RAAS Critical Care Therapeutics Revenue in Global (2016-2021)
7.12.5 Shanghai RAAS Key News
7.13 China Biologic Products
7.13.1 China Biologic Products Corporate Summary
7.13.2 China Biologic Products Business Overview
7.13.3 China Biologic Products Critical Care Therapeutics Major Product Offerings
7.13.4 China Biologic Products Critical Care Therapeutics Revenue in Global (2016-2021)
7.13.5 China Biologic Products Key News
7.14 Cosmo Pharmaceuticals
7.14.1 Cosmo Pharmaceuticals Corporate Summary
7.14.2 Cosmo Pharmaceuticals Business Overview
7.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Major Product Offerings
7.14.4 Cosmo Pharmaceuticals Critical Care Therapeutics Revenue in Global (2016-2021)
7.14.5 Cosmo Pharmaceuticals Key News
7.15 King Pharmaceuticals
7.15.1 King Pharmaceuticals Corporate Summary
7.15.2 King Pharmaceuticals Business Overview
7.15.3 King Pharmaceuticals Critical Care Therapeutics Major Product Offerings
7.15.4 King Pharmaceuticals Critical Care Therapeutics Revenue in Global (2016-2021)
7.15.5 King Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Critical Care Therapeutics Market Opportunities & Trends in Global Market
Table 2. Critical Care Therapeutics Market Drivers in Global Market
Table 3. Critical Care Therapeutics Market Restraints in Global Market
Table 4. Key Players of Critical Care Therapeutics in Global Market
Table 5. Top Critical Care Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Critical Care Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Critical Care Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Critical Care Therapeutics Product Type
Table 9. List of Global Tier 1 Critical Care Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Critical Care Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals